SIBN.NASDAQSi-bone, INC

Form 4: SI-BONE Director John Freund Receives RSU Grant

Sentiment:

Director Equity Grant


Director John Freund was granted 10,957 restricted stock units as part of his compensation for service on the SI-BONE board.

Summary

  • Director John Freund acquired 10,957 restricted stock units (RSUs) on June 4, 2026.
  • Each RSU represents a contingent right to receive one share of SI-BONE common stock.
  • The units vest 100% on the earlier of the next annual general meeting or one year from the vesting commencement date, contingent on continued board service.
  • Following this transaction, the director holds 54,258 shares directly and 91,767 shares indirectly through a family partnership.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial outlook.

Positives

  • Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

  • None identified; this is a standard equity compensation disclosure.

Risks

  • Vesting is subject to the director's continuous service on the Board of Directors.

Future Outlook

The RSUs are expected to vest in full within one year, subject to continued board service.

Management Comments

  • The reporting person disclaims beneficial ownership of securities held by the John Freund Family Partnership IV, L.P., except to the extent of his pecuniary interest therein.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are a standard corporate governance practice in the medical device sector to ensure board alignment with company performance.

Comparison to Industry Standards

  • The grant structure is consistent with standard equity compensation packages for board members of mid-cap medical technology companies.

Related Party Transactions

  • The reporting person is a general partner of the John Freund Family Partnership IV, L.P., which holds 91,767 shares of the issuer.

Stakeholder Impact

  • Minimal impact on shareholders as this is a standard compensation event.

Next Steps

  • Vesting of the 10,957 RSUs upon the next annual general meeting or one year from the grant date.

Key Dates

DateDescription
06/04/2026Date of the RSU grant transaction.
06/08/2026Date of filing.

Keywords

SI-BONE, SIBN, Form 4, Insider Trading, Director Compensation, Restricted Stock Units

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.